“Argyrol Pharmaceuticals promises that an injection of cash from its future revenues–10% of profits–could be a cure for the Barnes Foundation’s financial difficulties, which first prompted the relocation.”
“Argyrol Pharmaceuticals promises that an injection of cash from its future revenues–10% of profits–could be a cure for the Barnes Foundation’s financial difficulties, which first prompted the relocation.”